Biotech start-up Normunity, Inc. has exited stealth with a $65 million Series A to create a new class of medicines that target novel I-O mechanisms, which free the body’s normal immunity against ...

March 3, 2026 • The focus of the hearing is likely to be on how Kristi Noem is pursuing President Trump's mass deportation efforts in his second term, after two U.S. citizens were killed by ...